The DNA analysis chip producer has revealed a WeDoctor investment that likely formed part of the $56m in funding it closed last month.

The result is a new record for University of Pittsburgh and includes two businesses delivering surgical apparatus and one developing a poisoning antibody.

UC Berkeley spinout Mammoth Biosciences emerged from stealth in February 2018 with a Crispr-based approach for detecting diseases in DNA or RNA sequences.

Ascension Ventures led a round that will fund the overseas commercialisation of Healthmyne's cancer imaging analysis software.

Digital pharmacy MedAvail raised $16.6m in a round featuring Express Scripts, with the corporate taking a board seat through its investment.

The healthcare automation technology provider received $32.8m in a round featuring Ascension Ventures, boosting its equity funding to $68m in total.

Institute for Research in Immunology and Cancer has secured funding from CECR, the same government agency that supported its launch ten years ago.

Nan Fung Life Sciences and Lam Research Capital both invested as the DNA sequencing system developer concluded its series B round.

Cancer immunotherapy startup Curon Biopharmaceutical has raised $150m in series A funding from backers including the WuXi AppTec-backed 6 Dimensions Capital.